These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 30614478)

  • 1. Does end-of-treatment FDG-PET improve outcomes in follicular lymphoma? - Authors' reply.
    Trotman J; Barrington SF; Meignan M;
    Lancet Oncol; 2019 Jan; 20(1):e5. PubMed ID: 30614478
    [No Abstract]   [Full Text] [Related]  

  • 2. Does end-of-treatment FDG-PET improve outcomes in follicular lymphoma?
    Adams HJA; Kwee TC
    Lancet Oncol; 2019 Jan; 20(1):e4. PubMed ID: 30614476
    [No Abstract]   [Full Text] [Related]  

  • 3. Prognostic value of early 18 fluorodeoxyglucose positron emission tomography and gallium-67 scintigraphy in aggressive lymphoma: a prospective comparative study.
    Fruchart C; Reman O; Le Stang N; Musafiri D; Cheze S; Macro M; Switsers O; Aide N; Liegard M; Levaltier X; Peny AM; Leporrier M; Bardet S
    Leuk Lymphoma; 2006 Dec; 47(12):2547-57. PubMed ID: 17169799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FDG PET in follicular lymphoma: more than a staging test?
    Ravi Kumar AS; Tam C; Hofman MS
    Leuk Lymphoma; 2017 Jul; 58(7):1521-1523. PubMed ID: 28092995
    [No Abstract]   [Full Text] [Related]  

  • 5. The usefulness of (18)F-fluorodeoxyglucose positron emission tomography ((18)F-FDG-PET) and a comparison of (18)F-FDG-pet with (67)gallium scintigraphy in the evaluation of lymphoma: relation to histologic subtypes based on the World Health Organization classification.
    Tsukamoto N; Kojima M; Hasegawa M; Oriuchi N; Matsushima T; Yokohama A; Saitoh T; Handa H; Endo K; Murakami H
    Cancer; 2007 Aug; 110(3):652-9. PubMed ID: 17582800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systematic Review on the Additional Value of 18F-Fluoro-2-Deoxy-D-Glucose Positron Emission Tomography in Staging Follicular Lymphoma.
    Adams HJ; Nievelstein RA; Kwee TC
    J Comput Assist Tomogr; 2017 Jan; 41(1):98-103. PubMed ID: 27560022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Posterior scapular lymph nodes in a patient with follicular lymphoma on whole-body 2-deoxy-2-[18F]-fluoro-D-glucose (18F-FDG) positron emission tomography/computed tomography (PET/CT).
    Mahmood S; Martínez de Llano SR
    Rev Esp Med Nucl; 2008; 27(3):202-3. PubMed ID: 18570863
    [No Abstract]   [Full Text] [Related]  

  • 8. Use of FDG PET/CT in identification of bone marrow involvement in diffuse large B cell lymphoma and follicular lymphoma: comparison with iliac crest bone marrow biopsy.
    Teagle AR; Barton H; Charles-Edwards E; Dizdarevic S; Chevassut T
    Acta Radiol; 2017 Dec; 58(12):1476-1484. PubMed ID: 28382828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spontaneous regression of follicular, mantle cell, and diffuse large B-cell non-Hodgkin's lymphomas detected by FDG-PET imaging.
    Kumar R; Bhargava P; Zhuang H; Yu JQ; Schuster SJ; Alavi A
    Clin Nucl Med; 2004 Nov; 29(11):685-8. PubMed ID: 15483478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of FDG-PET in the initial staging of 142 patients with follicular lymphoma: a retrospective study from the FOLL05 randomized trial of the Fondazione Italiana Linfomi.
    Luminari S; Biasoli I; Arcaini L; Versari A; Rusconi C; Merli F; Spina M; Ferreri AJ; Zinzani PL; Gallamini A; Mastronardi S; Boccomini C; Gaidano G; D'Arco AM; Di Raimondo F; Carella AM; Santoro A; Musto P; Federico M
    Ann Oncol; 2013 Aug; 24(8):2108-12. PubMed ID: 23585513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PET for follicular lymphoma: a work in progress!
    Wirth A
    Leuk Lymphoma; 2007 Aug; 48(8):1463-4. PubMed ID: 17701573
    [No Abstract]   [Full Text] [Related]  

  • 12. 18F-fluoro-deoxy-glucose positron emission tomography (18F-FDG-PET) visualizes follicular lymphoma irrespective of grading.
    Wöhrer S; Jaeger U; Kletter K; Becherer A; Hauswirth A; Turetschek K; Raderer M; Hoffmann M
    Ann Oncol; 2006 May; 17(5):780-4. PubMed ID: 16497824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FDG PET/CT versus CT, MR imaging, and 67Ga scintigraphy in the posttherapy evaluation of malignant lymphoma.
    Okada M; Sato N; Ishii K; Matsumura K; Hosono M; Murakami T
    Radiographics; 2010; 30(4):939-57. PubMed ID: 20631361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Basal (18)F-FDG PET/CT in follicular lymphoma: A comparison of metabolic and clinical variables in the prognostic assessment.
    Jiménez Londoño GA; García Vicente AM; Poblete García VM; Amo-Salas M; Calle Primo C; Ibañez García Á; Martínez Sanchís B; López-Fidalgo JF; Solano Ramos F; Martínez Hellín A; Díaz Morfa M; Soriano Castrejón Á
    Rev Esp Med Nucl Imagen Mol; 2016; 35(5):298-305. PubMed ID: 27312693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. End-therapy positron emission tomography for treatment response assessment in follicular lymphoma: a systematic review and meta-analysis.
    Pyo J; Won Kim K; Jacene HA; Sakellis CG; Brown JR; Van den Abbeele AD
    Clin Cancer Res; 2013 Dec; 19(23):6566-77. PubMed ID: 24052020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prognostic role of post-induction FDG-PET in patients with follicular lymphoma: a subset analysis from the FOLL05 trial of the Fondazione Italiana Linfomi (FIL).
    Luminari S; Biasoli I; Versari A; Rattotti S; Bottelli C; Rusconi C; Merli F; Spina M; Ferreri AJ; Zinzani PL; Gallamini A; Franceschetto A; Boccomini C; Franceschetti S; Salvi F; Raimondo FD; Carella AM; Micol Q; Balzarotti M; Musto P; Federico M
    Ann Oncol; 2014 Feb; 25(2):442-7. PubMed ID: 24412823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Debate on the value of end-of-treatment FDG-PET response evaluation in follicular lymphoma.
    Adams HJA; Kwee TC
    Acta Oncol; 2017 Dec; 56(12):1789-1791. PubMed ID: 28712315
    [No Abstract]   [Full Text] [Related]  

  • 18. Opportunities and limitations of bone marrow biopsy and bone marrow FDG-PET in lymphoma.
    Adams HJ; Nievelstein RA; Kwee TC
    Blood Rev; 2015 Nov; 29(6):417-25. PubMed ID: 26113144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Positron emission tomography and gallium metabolic imaging in lymphoma.
    Coiffier B
    Curr Oncol Rep; 2001 May; 3(3):266-70. PubMed ID: 11296138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 18F-fluorodeoxyglucose positron emission tomography (18F-FDG-PET) does not visualize follicular lymphoma of the duodenum.
    Hoffmann M; Chott A; Püspök A; Jäger U; Kletter K; Raderer M
    Ann Hematol; 2004 May; 83(5):276-8. PubMed ID: 15060746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.